Oncoarendi Therapeutics SA operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oncoarendi Therapeutics SA with three other
pharmaceutical manufacturers in Europe:
Bonesupport Holding AB
sales of 180.86 million Swedish Kronor [US$20.84 million]
of which 61%
was CERAMENT BVF),
Biomed Lublin Wytwornia Surowic I Szczepionek SA
(40.16 million Polish New Zlotys [US$10.23 million]
of which 100%
was Traditional Segment), and
based in FRANCE
(9.34 million Euros [US$10.95 million]
of which 68%
was Research & Development Tax Credit).